Standardising Serialisation: The Deadly World of Falsified and Substandard Medicines
Hosted By : Andrea CharlesJune 19, 2012
Rate this Podcast:
(4.0 Stars | 1 Vote)
About this Podcast...
Just in the last few months, another dangerous fake drug made its way into the United States, a bogus version of the cancer drug Avastin surfaced in clinics across America in California, Illinois, and Texas. Recent changes to the EU Falsified Medicines Act mean that by 2015 most pharmaceutical companies trading in European countries will have to serialise their products, primarily using 2D data matrix barcodes. In this Pharma IQ exclusive AEI Scholar Roger Bate reveals how far-reaching the deadly business of counterfeit drugs has really become. Don't have the technology to listen to a podcast? Read the interview here: Roger Bate on the Deadly World of Falsified Medicines and the Financial Impact of Serialisation
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
Rate this Podcast:
(4.0 Stars | 1 Vote)
Events of Interest
-
Regenerative Medicine and Barriers to Commercialisation Online Summit 2011
October 25, 2011
Register Now -
Adverse Event Reporting Online Training Course 2011
August 3, 2011
Register Now -
Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security
December 13, 2011
Register Now -
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches
February 9, 2012
Register Now





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!